Immune System Disorders (+ Autoimmune)

Clients Success Stories:
Disability Benefits for Immune System Disorders (+ Autoimmune)

Plus additional resources on getting disability benefits for Immune System Disorders (+ Autoimmune)

What Social Security lists for Immune System Disorders (+ Autoimmune)

Immune System Disorders that may qualify for disability benefits are evaluated under Section 14.00 of Social Security’s Listing of Impairments – Adult Listings.

SSA organizes Immune System Disorders into 3 categories: Autoimmune disorders; Immune deficiency disorders, and HIV infection.

Disorders evaluated for disability benefits under this section include:

  • Systemic lupus erythematosus (Lupus)
  • Systemic vasculitis
  • Systemic sclerosis (scleroderma)
  • CREST syndrome (calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia)
  • Diffuse cutaneous systemic sclerosis
  • Diffuse scleroderma
  • Localized scleroderma (linear scleroderma and morphea)
  • Disseminated morphea
  • Shulman’s disease (diffuse fasciitis with eosinophilia)
  • Eosinophilia-myalgia syndrome
  • Polymyositis
  • Dermatomyositis
  • Inflammatory arthritis associated with:
    • Reiter’s syndrome
    • Ankylosing spondylitis
    • Psoriatic arthritis
    • Whipple’s disease
    • Behçet’s disease
    • Inflammatory bowel disease
    • Rheumatoid arthritis
    • Sjögren’s syndrome
    • Crystal deposition disorders (gout and pseudogout)
    • Lyme disease
  • Primary Immune deficiency disorders (congenital) such as:
    • X-linked agammaglobulinemia
    • thymic hypoplasia (DiGeorge syndrome)
    • severe combined immunodeficiency (SCID)
    • chronic granulomatous disease (CGD)
    • C1 esterase inhibitor deficiency
  • Medication-induced immune suppression
  • HIV infection, including acquired immune deficiency syndrome (AIDS), and disorders associated with HIV infection:
    • Multicentric Castleman disease (MCD)
    • Primary central nervous system lymphoma (PCNSL)
    • Primary effusion lymphoma (PEL)
    • Progressive multifocal leukoencephalopathy (PML)
    • Pulmonary Kaposi sarcoma (KS)